{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:34:19Z","timestamp":1787063659117,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>India has a functional and mature National Regulatory Authority which ensures that vaccines manufactured and used in the country are safe. Monitoring adverse events post-licensure is equally critical to identify infrequent adverse events due to the vaccine product.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>This was a cross-sectional observational qualitative study done in a Metropolitan city in Maharashtra from January 2017 to June 2018. Focus group discussions (FGDs) were conducted with healthcare workers and stakeholders involved in adverse event following immunization (AEFI) surveillance in the city. The data obtained were transcribed and analyzed using the inductive method. Thematic analysis was done using the grounded theory. Data were analyzed using ATLAS ti 5.7.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>It was found that both active and passive surveillance were being followed in the study area helped in improving reporting rates and in early detection and management of adverse events. It was noted that there was no proper training provided to doctors in the private sector. Reporting of adverse events depended upon a number of factors such as clinical seriousness, temporal proximity to vaccination and health care workers\u2019 awareness of and obligation to report particular adverse events, fear of blame, time pressures in completing a report, and confusion in whose responsibility it was to report.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Mandatory training of all private practitioners conducting immunizations, CHVs to work in collaboration with private doctors for active surveillance of AEFI, and online reporting to be made available for easy reporting. Proper counseling of mothers regarding giving paracetamol to the vaccine beneficiaries. Greater convergence is required between national regulators, and vaccine pharmacovigilance stakeholders including Central drugs standard control organisation (CDSCO), Pharmacovigilance programme of India (PvPI), and AEFI surveillance program, especially at the city and state level is required to handle vaccine safety issues at various levels in a faster and more effective manner.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijcm.ijcm_42_24","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:03:31Z","timestamp":1740384211000},"page":"S90-S97","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Qualitative Study to Assess Challenges Faced During AEFI Surveillance"],"prefix":"10.4103","volume":"50","author":[{"given":"Sophie","family":"Simon","sequence":"first","affiliation":[{"name":"Postdoctoral Research Fellow, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Rawat","sequence":"additional","affiliation":[{"name":"Assistant Professor, Govt Doon Medical College, Dehradun, Uttarakhand, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Sangam","sequence":"additional","affiliation":[{"name":"Assistant Professor, Department of Community Medicine LTMMC and GH Sion Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanan D.","family":"Velhal","sequence":"additional","affiliation":[{"name":"Ex -HOD, SETH G S Medical College, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"R1-20260421","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12098-017-2532-9","article-title":"Vaccine safety and surveillance for adverse events following immunization (AEFI) in India","volume":"85","author":"Joshi","year":"2018","journal-title":"Indian J Pediatr"},{"key":"R2-20260421","first-page":"828","article-title":"Vaccinovigilance in Europe-Need for timeliness, standardization and resource","volume":"82","author":"Lankinen","year":"2004","journal-title":"Bull World Health Organ"},{"key":"R3-20260421","article-title":"Global Manual on surveillance of Adverse Events Following Immunization","year":"2012","journal-title":"WHO Western Pacific Regional Office"},{"key":"R4-20260421","article-title":"Causality Assessment of an Adverse Event Following Immunization (AEFI)","year":"2013"},{"key":"R5-20260421","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"},{"key":"R6-20260421","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1016\/j.vaccine.2017.06.027","article-title":"Application of the revised WHO causality assessment protocol for adverse events following immunization in India","volume":"35","author":"Singh","year":"2017","journal-title":"Vaccine"},{"key":"R8-20260421","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.vaccine.2010.04.002","article-title":"Surveillance for adverse events following immunization (AEFI) in Switzerland-1991-2001","volume":"28","author":"Schumacher","year":"2010","journal-title":"Vaccine"},{"key":"R9-20260421","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1016\/j.vaccine.2015.04.060","article-title":"Surveillance of adverse events following immunization in China: Past, present, and future","volume":"33","author":"Liu","year":"2015","journal-title":"Vaccine"},{"key":"R10-20260421","doi-asserted-by":"crossref","first-page":"474","DOI":"10.26719\/2010.16.5.474","article-title":"Surveillance of adverse events following immunization: 10 years\u2019 experience in Oman","volume":"16","author":"Al Awaidy","year":"2010","journal-title":"East Mediterr Health J"},{"key":"R11-20260421","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1080\/21645515.2017.1384105","article-title":"Reporting of adverse events following immunizations in Ghana\u2013Using disproportionality analysis reporting ratios","volume":"14","author":"Ankrah","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"R12-20260421","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1016\/j.vaccine.2014.07.020","article-title":"Active surveillance of adverse events following childhood immunization in Singapore","volume":"32","author":"Thoon","year":"2014","journal-title":"Vaccine"},{"key":"R13-20260421","doi-asserted-by":"crossref","first-page":"662","DOI":"10.4161\/hv.19478","article-title":"Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010","volume":"8","author":"Parrella","year":"2014","journal-title":"Hum Vacc Immunother"},{"key":"R14-20260421","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.socscimed.2004.08.055","article-title":"Beyond blame: Cultural barriers to medical incident reporting","volume":"60","author":"Waring","year":"2005","journal-title":"Soc Sci Med"},{"key":"R15-20260421","doi-asserted-by":"crossref","first-page":"1","DOI":"10.11604\/pamj.2017.28.308.12730","article-title":"Evaluation of the adverse events following immunizations surveillance system in harare City, Zimbabwe, 2016: A descriptive cross sectional study","volume":"28","author":"Zvanaka","year":"2017","journal-title":"Pan Afr Med J"},{"key":"R16-20260421","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/1472-6963-13-313","article-title":"Healthcare providers\u2019 knowledge, experience and challenges of reporting adverse events following immunisation: A qualitative study","volume":"13","author":"Parrella","year":"2013","journal-title":"BMC Health Serv Res"},{"key":"R17-20260421","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s40272-014-0075-3","article-title":"Awareness and utilization of reporting pathways for adverse events following immunization: Online survey among pediatricians in Russia and Germany","volume":"16","author":"Muehlhans","year":"2014","journal-title":"Pediatr Drugs"},{"key":"R18-20260421","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4161\/hv.34360","article-title":"Routine surveillance of adverse events following immunization as an important tool to monitor vaccine safety","volume":"11","author":"Alicino","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"R20-20260421","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s13312-013-0210-1","article-title":"Adverse event following immunization (AEFI) surveillance in India: Position paper of Indian Academy of Pediatrics, 2013","volume":"50","author":"Chitkara","year":"2013","journal-title":"Indian Pediatr"},{"key":"R21-20260421","article-title":"GVSI Bulletin December 2013","year":"2013"},{"key":"R22-20260421","article-title":"Surveillance of adverse events following immunisation in Australia annual report","author":"Dey","year":"2015"},{"key":"R23-20260421","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40264-017-0520-7","article-title":"Evaluation of \u2018SAEFVIC\u2019, A pharmacovigilance surveillance scheme for the spontaneous reporting of adverse events following immunisation in Victoria, Australia","volume":"40","author":"Clothier","year":"2017","journal-title":"Drug Saf"},{"key":"R24-20260421","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/CVI.00541-12","article-title":"Surveillance for adverse events following immunization from 2008 to 2011 in Zhejiang province, China","volume":"20","author":"Hu","year":"2013","journal-title":"Clin Vaccine Immunol"}],"container-title":["Indian Journal of Community Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_42_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:00:34Z","timestamp":1786647634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijcm.ijcm_42_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":22,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijcm.ijcm_42_24","relation":{},"ISSN":["0970-0218","1998-3581"],"issn-type":[{"value":"0970-0218","type":"print"},{"value":"1998-3581","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"2024-01-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}